Peter Crocker
| Peter Crocker | |
| Occupation | Co-founder and CTO of Aidy |
|---|---|
| Known for | Co-founding Aidy (YC W24) |
| Education | BA and MEng, MIT |
Peter Crocker is an American technology entrepreneur and the co-founder and chief technology officer (CTO) of Aidy, a mobile application designed to help people manage chronic health conditions. The company was part of Y Combinator's Winter 2024 batch.[1]
Career
Prior to founding Aidy, Crocker worked as a machine learning researcher for several biotechnology companies.[1] He holds a Bachelor of Arts and a Master of Engineering degree from the Massachusetts Institute of Technology (MIT).
Crocker co-founded Aidy in 2024 alongside Max Williamson. The company is based in San Francisco, California. Aidy is a mobile application in the consumer health and digital health space that helps users manage chronic health conditions, with an initial focus on Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis.[2]
The app allows users to log symptoms, diet, and treatments, and uses clinical indices to track disease severity and trends over time. It employs machine learning models and large language model (LLM) technology, combined with structured questionnaire responses, to identify patterns between diet, treatment adherence, and symptoms. The application also generates physician-friendly reports intended to supplement clinical care by providing doctors with up-to-date information on a patient's condition.[2]
According to the founders, the idea for Aidy emerged after a friend with IBD expressed frustration at the lack of adequate applications for managing the disease. The founders had previously gone through a period they described as "pivot hell" before settling on the concept. Crocker's background in machine learning research at biotech companies, combined with Williamson's experience in public health policy, informed the development of the product.[1]
Key features of the Aidy app include food tracking through photo recognition, symptom monitoring for flare detection, treatment adherence tools, trend analysis, exportable physician reports, and personalized health education content.[2]
References